EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dynamic risk stratification in patients with follicular thyroid carcinoma treated with lobectomy

Haruhiko Yamazaki iD, Kiminori Sugino iD, Ryohei Katoh, Kenichi Matsuzu, Wataru Kitagawa, Mitsuji Nagahama, Aya Saito, Koichi Ito

European Thyroid Journal · 2025

DOI: 10.1530/etj-25-0154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Thyroid Journal, 2025. Verfasst von Haruhiko Yamazaki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama City, Kanagawa, Japan. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Adenocarcinoma, Follicular, Thyroidectomy. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Previous studies showed that dynamic risk stratification (DRS) was also useful in differentiated thyroid carcinoma patients with lobectomy or total thyroidectomy without radioactive iodine. The aim of this study was to evaluate the DRS system in patients with follicular thyroid carcinoma (FTC) who underwent lobectomy alone.

Methods

In total, 161 patients with FTC who were diagnosed between January 2005 and December 2014 and underwent lobectomy alone were included in this study.

Results

Of the 161 patients with FTC, the DRS system classified 159 patients (99%) as having an excellent response, and 2 (1%) as having a structural-incomplete response. The 10-year disease-free survival (DFS) rates of patients with excellent response and structural-incomplete response were 93.5% and 0%, respectively ( P < 0.001). Of the 54 patients with VI ≥ 2, the 10-year DFS rates of patients with excellent response ( n = 53) and structural-incomplete response ( n = 1) were 83.2% and 0%, respectively ( P < 0.001). Of the 53 patients with excellent response, 10 patients experienced disease recurrence. Among Of these ten patients, the duration between initial thyroid surgery and recurrence was 2–5 years in one, 5–8 years in two, 8–10 years in four, and 10 years or more in three patients, respectively.

Conclusion

Long-term follow-up may be needed in FTC patients treated with lobectomy alone even though they had an excellent response to initial thyroid surgery, especially in patients with a higher risk of recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsAdenocarcinoma, FollicularThyroidectomyHumansMaleFemaleMiddle AgedAdultAgedRisk AssessmentDisease-Free SurvivalRetrospective StudiesYoung AdultNeoplasm Recurrence, LocalTreatment OutcomeAdolescent

Stichwörter der Autor:innen

dynamic risk stratificationfollicular thyroid carcinomaprognosis

Autor:innen und Institutionen

  • Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama City, Kanagawa, Japan.
  • Department of Surgery, Ito Hospital, Tokyo, Japan.
  • Department of Pathology, Ito Hospital, Tokyo, Japan.
  • Department of Surgery, Yokohama City University School of Medicine, Yokohama City, Kanagawa, Japan.

ORCID-Profile: Haruhiko Yamazaki, Kiminori Sugino

Zitieren

APA

Yamazaki, H., Sugino, K., Katoh, R., Matsuzu, K., Kitagawa, W., Nagahama, M., Saito, A., & Ito, K. (2025). Dynamic risk stratification in patients with follicular thyroid carcinoma treated with lobectomy. European Thyroid Journal. https://doi.org/10.1530/etj-25-0154

Vancouver

Yamazaki H, Sugino K, Katoh R, Matsuzu K, Kitagawa W, Nagahama M, et al. Dynamic risk stratification in patients with follicular thyroid carcinoma treated with lobectomy. European Thyroid Journal. 2025. doi:10.1530/etj-25-0154

BibTeX
@article{Yamazaki2025,
  author = {Yamazaki, Haruhiko and Sugino, Kiminori and Katoh, Ryohei and Matsuzu, Kenichi and Kitagawa, Wataru and Nagahama, Mitsuji and Saito, Aya and Ito, Koichi},
  title = {Dynamic risk stratification in patients with follicular thyroid carcinoma treated with lobectomy},
  journal = {European Thyroid Journal},
  year = {2025},
  doi = {10.1530/etj-25-0154}
}
Kostenlos starten →